Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Egypt · Delayed Price · Currency is EGP

88.00

+1.14 (1.31%)

At close: Jun 4, 2026

Revenue by Segment

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	9.44B	7.59B	5.23B	3.96B	3.41B
Pharmaceuticals Growth	24.38%	45.09%	32.27%	16.03%	18.13%
Total	9.44B	7.59B	5.23B	3.96B	3.41B
Total Growth	24.38%	45.09%	32.27%	16.03%	18.13%

Revenue by Geography

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Egypt	6.42B	5.05B	3.62B	2.98B	2.65B
Egypt Growth	27.10%	39.45%	21.50%	12.62%	16.79%
Export	2.97B	2.50B	1.59B	965.10M	752.98M
Export Growth	18.69%	57.04%	64.96%	28.17%	22.31%
Unallocated	49.37M	35.84M	15.08M	7.39M	7.11M
Unallocated Growth	37.76%	137.64%	104.12%	3.94%	244.63%
Total	9.44B	7.59B	5.23B	3.96B	3.41B
Total Growth	24.38%	45.09%	32.26%	16.04%	18.13%

Source: S&P Global Market Intelligence.